Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Genetic variations in CYP 2C9 (e.g., slow metabolizers) may affect phenytoin levels
Weight loss results In a 2022 review of 22 studies that included more than 17,000 people with or without type 2 diabetes treated with semaglutide or liraglutide: More than 50% of participants treated with either semaglutide or liraglutide lost 5% or more of their starting weight after an average of 39 weeks on the medicine About 17% of participants lost 10% or more of their body weight in the same period A phase 3 clinical trial studied treatment with tirzepatide in people with obesity and found that it produced substantial and sustained weight loss at various dose strengths
This means it works by increasing insulin release in response to meals and lowering blood sugar levels
Its a promising option for people looking to lose weight, especially when paired with guidance from a provider who understands how it works and how to support your body during treatment
